Veritable’s Medtronic MDT Stock Holding History

Veritable’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-40,332	Closed	-$3.55M	–	492
2023 Q2	$3.55M	Buy	40,332 +583	+1%	+$50.2K	0.06%	154
2023 Q1	$3.2M	Buy	39,749 +3,723	+10%	+$303K	0.05%	171
2022 Q4	$2.8M	Sell	36,026 -3,227	-8%	-$262K	0.05%	183
2022 Q3	$3.17M	Sell	39,253 -7,526	-16%	-$676K	0.06%	159
2022 Q2	$4.2M	Buy	46,779 +125	+0.3%	+$12.7K	0.08%	139
2022 Q1	$5.18M	Buy	46,654 +1,385	+3%	+$146K	0.08%	135
2021 Q4	$4.68M	Buy	45,269 +484	+1%	+$56K	0.07%	140
2021 Q3	$5.61M	Sell	44,785 -962	-2%	-$125K	0.09%	121
2021 Q2	$5.68M	Sell	45,747 -203	-0.4%	-$25.5K	0.09%	118
2021 Q1	$5.43M	Buy	45,950 +187	+0.4%	+$21.9K	0.09%	114
2020 Q4	$5.36M	Sell	45,763 -3,845	-8%	-$423K	0.1%	113
2020 Q3	$5.16M	Buy	49,608 +17	+0%	+$1.71K	0.1%	105
2020 Q2	$4.55M	Sell	49,591 -2,556	-5%	-$245K	0.1%	106
2020 Q1	$4.7M	Sell	52,147 -1,135	-2%	-$121K	0.11%	100
2019 Q4	$6.04M	Buy	53,282 +2,554	+5%	+$280K	0.11%	110
2019 Q3	$5.51M	Buy	50,728 +305	+0.6%	+$31.8K	0.11%	111
2019 Q2	$4.91M	Buy	50,423 +4,123	+9%	+$376K	0.1%	121
2019 Q1	$4.22M	Buy	46,300 +85	+0.2%	+$7.61K	0.08%	135
2018 Q4	$4.2M	Buy	46,215 +529	+1%	+$49.4K	0.1%	124
2018 Q3	$4.49M	Sell	45,686 -807	-2%	-$74.6K	0.09%	124
2018 Q2	$3.98M	Buy	46,493 +2,990	+7%	+$250K	0.08%	136
2018 Q1	$3.49M	Sell	43,503 -760	-2%	-$62.7K	0.08%	146
2017 Q4	$3.57M	Sell	44,263 -1,365	-3%	-$109K	0.07%	142
2017 Q3	$3.55M	Sell	45,628 -363	-0.8%	-$30.1K	0.07%	146
2017 Q2	$4.08M	Buy	45,991 +1,666	+4%	+$140K	0.09%	134
2017 Q1	$3.57M	Sell	44,325 -959	-2%	-$74.9K	0.09%	133
2016 Q4	$3.23M	Sell	45,284 -2,318	-5%	-$182K	0.08%	148
2016 Q3	$4.11M	Buy	47,602 +1,872	+4%	+$163K	0.1%	122
2016 Q2	$3.97M	Buy	45,730 +2,108	+5%	+$170K	0.1%	120
2016 Q1	$3.27M	Sell	43,622 -19,088	-30%	-$1.44M	0.09%	136
2015 Q4	$4.82M	Buy	62,710 +9,462	+18%	+$712K	0.13%	111
2015 Q3	$3.56M	Sell	53,248 -7,000	-12%	-$516K	0.1%	131
2015 Q2	$4.46M	Sell	60,248 -155,610	-72%	-$11.9M	0.12%	119
2015 Q1	$16.8M	Buy	215,858 +113,202	+110%	+$8.58M	0.35%	42
2014 Q4	$7.41M	Buy	102,656 +47,951	+88%	+$3.33M	0.15%	116
2014 Q3	$3.39M	Sell	54,705 -905	-2%	-$57.5K	0.07%	186
2014 Q2	$3.55M	Buy	55,610 +714	+1%	+$43.4K	0.07%	180
2014 Q1	$3.38M	Buy	54,896 +800	+1%	+$46.6K	0.07%	181
2013 Q4	$3.1M	Sell	54,096 -8,203	-13%	-$465K	0.07%	184
2013 Q3	$3.32M	Buy	62,299 +2,835	+5%	+$153K	0.08%	173
2013 Q2	$3.06M	Buy	+59,464	New	+$2.94M	0.07%	182

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Veritable's MDT Position: Q3 2023 in Review

Veritable sold out of Medtronic (MDT) in Q3 2023, closing a stake of 40,332 shares — an estimated $3.55M sold.

Veritable first reported a position in MDT in Q2 2013 and held it in 41 quarters. The position peaked at $16.8M in Q1 2015. 1,970 funds tracked by Wall St. Rank hold MDT as of Q3 2023.

Veritable reported no remaining Medtronic position as of Q3 2023 after selling out during the quarter.
Veritable sold 40,332 Medtronic shares in Q3 2023, an estimated $3.55M.
Veritable first reported a position in Medtronic in Q2 2013 and held it in 41 quarters.
Veritable's Medtronic position peaked at $16.8M in Q1 2015.
1,970 funds tracked by Wall St. Rank held Medtronic as of Q3 2023.

Based on Veritable's 13F filing for Q3 2023.